• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

光反应性硝基苯基底物衍生物对急性髓性白血病细胞中UDP-葡萄糖胺:β1-3半乳糖基-N-乙酰半乳糖胺-R(葡萄糖胺至N-乙酰半乳糖胺)β6-N-乙酰葡糖胺基转移酶的抑制作用

Inhibition of UDP-GlcNAc:Gal beta 1-3GalNAc-R (GlcNAc to GalNAc) beta 6-N-acetylglucosaminyltransferase from acute myeloid leukaemia cells by photoreactive nitrophenyl substrate derivatives.

作者信息

Toki D, Granovsky M A, Reck F, Kuhns W, Baker M A, Matta K L, Brockhausen I

机构信息

Department of Biochemistry, Hospital for Sick Children, Toronto, Ontario, Canada.

出版信息

Biochem Biophys Res Commun. 1994 Jan 28;198(2):417-23. doi: 10.1006/bbrc.1994.1061.

DOI:10.1006/bbrc.1994.1061
PMID:7802860
Abstract

Cells from patients with acute myeloid leukaemia (AML) contain an abnormally high UDP-GlcNAc: Gal beta 1-3GalNAc-R (GlcNAc to GalNAc) beta 6-N-acetylglucosaminyltransferase (core 2 beta 6-Gn-T) activity. Upon UV irradiation at 350 nm, the substrate Gal beta 1-3GalNAc alpha-p-nitrophenyl acted as an effective inhibitor for this enzyme but not for several other transferases. Preincubation with Gal beta 1-3GalNAc alpha-benzyl but not GalNAc alpha-benzyl protected core 2 beta 6-Gn-T from inhibition indicating that the inhibitor is specific for the substrate binding site of core 2 beta 6-Gn-T. A number of other nitrophenyl-sugar derivatives similarly acted as inhibitors for core 2 beta 6-Gn-T. GalNAc alpha-pnp at higher concentrations also inactivated UDP-Gal: GalNAc-R beta 3-galactosyltransferase from rat liver and AML cells and inhibition could be reduced by substrate protection. These results suggest that pnp-sugar derivatives may prove useful as specific inhibitors of glycosyltransferases and as affinity labels.

摘要

急性髓系白血病(AML)患者的细胞中,UDP-葡萄糖胺:Galβ1-3GalNAc-R(GlcNAc到GalNAc)β6-N-乙酰葡糖胺转移酶(核心2 β6-Gn-T)活性异常高。在350nm紫外线照射下,底物Galβ1-3GalNAcα-对硝基苯作为该酶的有效抑制剂,但对其他几种转移酶无效。用Galβ1-3GalNAcα-苄基而非GalNAcα-苄基预孵育可保护核心2 β6-Gn-T免受抑制,表明该抑制剂对核心2 β6-Gn-T的底物结合位点具有特异性。许多其他硝基苯基糖衍生物同样可作为核心2 β6-Gn-T的抑制剂。较高浓度的GalNAcα-pnp还可使大鼠肝脏和AML细胞中的UDP-Gal:GalNAc-R β3-半乳糖基转移酶失活,底物保护可降低抑制作用。这些结果表明,对硝基苯基糖衍生物可能作为糖基转移酶的特异性抑制剂和亲和标记物有用。

相似文献

1
Inhibition of UDP-GlcNAc:Gal beta 1-3GalNAc-R (GlcNAc to GalNAc) beta 6-N-acetylglucosaminyltransferase from acute myeloid leukaemia cells by photoreactive nitrophenyl substrate derivatives.光反应性硝基苯基底物衍生物对急性髓性白血病细胞中UDP-葡萄糖胺:β1-3半乳糖基-N-乙酰半乳糖胺-R(葡萄糖胺至N-乙酰半乳糖胺)β6-N-乙酰葡糖胺基转移酶的抑制作用
Biochem Biophys Res Commun. 1994 Jan 28;198(2):417-23. doi: 10.1006/bbrc.1994.1061.
2
Processing O-glycan core 1, Gal beta 1-3GalNAc alpha-R. Specificities of core 2, UDP-GlcNAc: Gal beta 1-3 GalNAc-R(GlcNAc to GalNAc) beta 6-N-acetylglucosaminyltransferase and CMP-sialic acid: Gal beta 1-3GalNAc-R alpha 3-sialyltransferase.O-聚糖核心1(Galβ1-3GalNAcα-R)的加工。核心2的特异性,UDP-N-乙酰葡糖胺:Galβ1-3GalNAc-R(从GlcNAc到GalNAc)β6-N-乙酰葡糖胺基转移酶和CMP-唾液酸:Galβ1-3GalNAc-Rα3-唾液酸转移酶。
Glycoconj J. 1993 Oct;10(5):381-94. doi: 10.1007/BF00731043.
3
UDP-GlcNAc: Gal beta 3GalNAc-mucin: (GlcNAc----GalNAc) beta 6-N-acetylglucosaminyltransferase and UDP-GlcNAc: Gal beta 3(GlcNAc beta 6) GalNAc-mucin (GlcNAc----Gal)beta 3-N-acetylglucosaminyltransferase from swine trachea epithelium.来自猪气管上皮的UDP-N-乙酰葡糖胺:β3半乳糖基-β-N-乙酰半乳糖胺-粘蛋白:(N-乙酰葡糖胺→N-乙酰半乳糖胺)β6-N-乙酰葡糖胺基转移酶和UDP-N-乙酰葡糖胺:β3(β6-N-乙酰葡糖胺)半乳糖基-β-N-乙酰半乳糖胺-粘蛋白(N-乙酰葡糖胺→半乳糖)β3-N-乙酰葡糖胺基转移酶
Mol Cell Biochem. 1991 Mar 13;101(2):125-43. doi: 10.1007/BF00229530.
4
Control of O-glycan synthesis: specificity and inhibition of O-glycan core 1 UDP-galactose:N-acetylgalactosamine-alpha-R beta 3-galactosyltransferase from rat liver.O-聚糖合成的调控:大鼠肝脏中O-聚糖核心1 UDP-半乳糖:N-乙酰半乳糖胺-α-R β3-半乳糖基转移酶的特异性及抑制作用
Biochem Cell Biol. 1992 Feb;70(2):99-108. doi: 10.1139/o92-015.
5
Mucin synthesis. II. Substrate specificity and product identification studies on canine submaxillary gland UDP-GlcNAc:Gal beta 1-3GalNAc(GlcNAc leads to GalNAc) beta 6-N-acetylglucosaminyltransferase.粘蛋白合成。II. 犬颌下腺UDP-N-乙酰葡糖胺:β1-3半乳糖基-N-乙酰半乳糖胺(N-乙酰葡糖胺→N-乙酰半乳糖胺)β6-N-乙酰葡糖胺基转移酶的底物特异性及产物鉴定研究
J Biol Chem. 1980 Dec 10;255(23):11253-61.
6
A coupled assay for UDP-GlcNAc:Gal beta 1-3GalNAc-R beta 1,6-N-acetylglucosaminyltransferase (GlcNAc to GalNAc).
Anal Biochem. 1992 Nov 1;206(2):262-6. doi: 10.1016/0003-2697(92)90364-d.
7
Mucin synthesis. Conversion of R1-beta 1-3Gal-R2 to R1-beta 1-3(GlcNAc beta 1-6)Gal-R2 and of R1-beta 1-3GalNAc-R2 to R1-beta 1-3(GlcNAc beta 1-6)GalNAc-R2 by a beta 6-N-acetylglucosaminyltransferase in pig gastric mucosa.黏蛋白合成。猪胃黏膜中的β6-N-乙酰氨基葡萄糖转移酶将R1-β1-3Gal-R2转化为R1-β1-3(GlcNAcβ1-6)Gal-R2,以及将R1-β1-3GalNAc-R2转化为R1-β1-3(GlcNAcβ1-6)GalNAc-R2。
Eur J Biochem. 1986 Jun 16;157(3):463-74. doi: 10.1111/j.1432-1033.1986.tb09690.x.
8
Mucin synthesis. The action of pig gastric mucosal UDP-GlcNAc:Gal beta 1-3(R1)GalNAc-R2 (GlcNAc to Gal) beta 3-N-acetylglucosaminyltransferase on high molecular weight substrates.粘蛋白合成。猪胃黏膜UDP-N-乙酰葡糖胺:β-半乳糖1-3(R1)N-乙酰半乳糖胺-R2(葡糖胺到半乳糖)β3-N-乙酰葡糖胺基转移酶对高分子量底物的作用。
Can J Biochem Cell Biol. 1984 Nov;62(11):1081-90. doi: 10.1139/o84-140.
9
The separation by liquid chromatography (under elevated pressure) of phenyl, benzyl, and O-nitrophenyl glycosides of oligosaccharides. Analysis of substrates and products for four N-acetyl-D-glucosaminyl-transferases involved in mucin synthesis.通过(高压)液相色谱法分离寡糖的苯基、苄基和邻硝基苯基糖苷。分析参与粘蛋白合成的四种N-乙酰-D-氨基葡萄糖基转移酶的底物和产物。
Carbohydr Res. 1983 Aug 16;120:3-16. doi: 10.1016/0008-6215(83)88002-1.
10
Biosynthesis of O-glycans in leukocytes from normal donors and from patients with leukemia: increase in O-glycan core 2 UDP-GlcNAc:Gal beta 3 GalNAc alpha-R (GlcNAc to GalNAc) beta(1-6)-N-acetylglucosaminyltransferase in leukemic cells.正常供体和白血病患者白细胞中O-聚糖的生物合成:白血病细胞中O-聚糖核心2 UDP-葡萄糖胺:半乳糖β3 N-乙酰半乳糖胺α-R(从葡萄糖胺到N-乙酰半乳糖胺)β(1-6)-N-乙酰葡糖胺基转移酶增加。
Cancer Res. 1991 Feb 15;51(4):1257-63.

引用本文的文献

1
Biosynthetic Machinery Involved in Aberrant Glycosylation: Promising Targets for Developing of Drugs Against Cancer.生物合成机制参与异常糖基化:开发抗癌药物的有前途的靶点。
Front Oncol. 2015 Jun 25;5:138. doi: 10.3389/fonc.2015.00138. eCollection 2015.
2
Acceptor specificities and selective inhibition of recombinant human Gal- and GlcNAc-transferases that synthesize core structures 1, 2, 3 and 4 of O-glycans.合成O-聚糖核心结构1、2、3和4的重组人半乳糖转移酶和N-乙酰葡糖胺转移酶的受体特异性及选择性抑制作用。
Biochim Biophys Acta. 2013 Aug;1830(8):4274-81. doi: 10.1016/j.bbagen.2013.04.001. Epub 2013 Apr 8.